eIF-2-alpha kinase GCN2 · SINGLE PROTEIN · Homo sapiens
This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.
Move to another high-traffic target or paste a specific ChEMBL target ID.
Structured disease, protein, and project context should read before the lower-level identity rail.
As of 2026-09-13Protein identity stays anchored to UniProt Q9P2K8. Use UniProt Q9P2K8 as the stable identity anchor, then attach disease evidence before program review.
Use UniProt Q9P2K8 as the stable identity anchor, then attach disease evidence before program review.
eIF-2-alpha kinase GCN2
Review this target as eIF-2-alpha kinase GCN2, mapped to UniProt Q9P2K8. Sequence length is 1649 aa.
Protein source · UniProt accession via ChEMBL component mappingKeep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.
This review treats eIF-2-alpha kinase GCN2 as ChEMBL target CHEMBL5358, mapped to UniProt Q9P2K8. Disease framing currently uses the Open Targets-ready proxy contract.
Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.
Choose the first block or source based on the question you are trying to answer.
Start here when your first question is whether eIF-2-alpha kinase GCN2 is the right protein anchor across sources, using UniProt Q9P2K8 as the stable mapping.
Jump to Protein ContextUse this block first when you need the strongest disease program and evidence level in one place.
Jump to Disease ContextOpen the one-page evidence card when you want the rationale, activity base, and attribution together.
Open Review-ready CardVerify identity, organism, and the fastest next research jumps from the same page.
| Preferred Name | eIF-2-alpha kinase GCN2 |
| Target Type | SINGLE PROTEIN |
| Organism | Homo sapiens |
| UniProt | Q9P2K8 |
Reviewable protein naming and mapping context for this target snapshot.
| Protein Label | eIF-2-alpha kinase GCN2 |
| UniProt Accession | Q9P2K8 |
| Component Type | Protein |
| Sequence Length | 1649 aa |
eIF-2-alpha kinase GCN2
Review this target as eIF-2-alpha kinase GCN2, mapped to UniProt Q9P2K8. Sequence length is 1649 aa.
| ChEMBL ID | pChEMBL | Type | Value (nM) | Phase |
|---|---|---|---|---|
| CHEMBL5200118 | 8.7 | IC50 | 2.0 | Preclinical |
| CHEMBL5571568 | 8.6 | IC50 | 2.5 | Preclinical |
| CHEMBL5202342 | 8.52 | IC50 | 3.0 | Preclinical |
| CHEMBL475251 | 8.48 | Kd | 3.3 | Clinical |
| CHEMBL5427321 | 8.4 | IC50 | 4.0 | Preclinical |
| CHEMBL603469 | 8.39 | Kd | 4.1 | Clinical |
| CHEMBL5209076 | 8.3 | IC50 | 5.0 | Preclinical |
| CHEMBL5190023 | 8.3 | IC50 | 5.0 | Preclinical |
| CHEMBL5179922 | 8.3 | IC50 | 5.0 | Preclinical |
| CHEMBL3407849 | 8.3 | IC50 | 5.0 | Preclinical |
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| single protein format | 96 | 454 | 6.9 |
| assay format | 25 | 21 | 6.9 |
| cell-based format | 25 | 36 | 6.9 |
| subcellular format | 22 | 0 | — |